Pediatric Eczema, Eosinophilic Esophagitis Linked
The Dermatology Digest
FEBRUARY 5, 2024
Management in the form of diet, drugs, and/or esophageal dilation — known as the “3 Ds” — is recommended to prevent long-term complications. Food and Drug Administration has expanded the indication for dupilumab (Dupixent, Sanofi, Regeneron Pharmaceuticals, Inc.)
Let's personalize your content